Physician profile
Ashley Conner
NPI 1255853933
$1,719.10
in general payments reported to CMS, 2019-2025
23 companies · $524 in 2025
The $524 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $303 · 2023: $572 · 2024: $319 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,298 · Education: $99.99 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,298.38 |
| Education | $99.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $382.92 | 2022-2025 | Xtandi, Myrbetriq |
| Procept Biorobotics Corporation | $209.54 | 2025 | |
| 180 Medical, INC. | $172.74 | 2022-2025 | Gentlecath, Gentlecath Glide |
| Halozyme INC | $141.38 | 2023 | |
| Sumitomo Pharma America, INC. | $124.70 | 2023-2025 | Orgovyx, Gemtesa |
| Merck Sharp & Dohme LLC | $122.63 | 2023-2024 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $55.92 | 2022-2025 | Erleada |
| Teleflex LLC | $54.10 | 2022-2025 | Urolift, Deknatel |
| Urogen Pharma, INC. | $45.24 | 2023 | Jelmyto |
| Olympus America INC. | $43.24 | 2025 | Itind System |
| Bayer Healthcare Pharmaceuticals INC. | $42.40 | 2022-2025 | |
| Myovant Sciences INC. | $41.25 | 2022 | |
| Tolmar, INC. | $35.93 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $35.25 | 2022 | |
| Boston Scientific Corporation | $30.75 | 2025 | Axonics |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $30.41 | 2025 | Xyosted |
| Abbvie INC. | $26.35 | 2024 | |
| Endo USA, INC. | $23.39 | 2025 | Aveed, Xiaflex |
| Ferring Pharmaceuticals INC. | $23.17 | 2024 | Adstiladrin |
| Pfizer INC. | $23.07 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $19.55 | 2025 | |
| Bioprotect Medical, INC. | $19.42 | 2024 | Bioprotect Balloon Implant System |
| Coloplast Corp | $15.75 | 2023 | Speedicath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Conner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.